[HTML][HTML] Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection

DR Goldstein, BM Tesar, S Akira… - The Journal of clinical …, 2003 - Am Soc Clin Investig
The Journal of clinical investigation, 2003Am Soc Clin Investig
The Toll-like receptors (TLRs) are recently discovered germline-encoded receptors on APCs
that are critically important in innate immune recognition of microbial pathogens. However,
their role in solid-organ transplantation is unknown. To explore this role, we employed a skin
allograft model using mice with targeted deletion of the universal TLR signal adaptor protein,
MyD88. We report that minor antigen–mismatched (HY-mismatched) allograft rejection
cannot occur in the absence of MyD88 signaling. Furthermore, we show that the inability to …
The Toll-like receptors (TLRs) are recently discovered germline-encoded receptors on APCs that are critically important in innate immune recognition of microbial pathogens. However, their role in solid-organ transplantation is unknown. To explore this role, we employed a skin allograft model using mice with targeted deletion of the universal TLR signal adaptor protein, MyD88. We report that minor antigen–mismatched (HY-mismatched) allograft rejection cannot occur in the absence of MyD88 signaling. Furthermore, we show that the inability to reject these allografts results from a reduced number of mature DCs in draining lymph nodes, leading to impaired generation of anti–graft-reactive T cells and impaired Th1 immunity. Hence, this work demonstrates that TLRs can be activated in a transplant setting and not solely by infections. These results link innate immunity to the initiation of the adaptive alloimmune response.
The Journal of Clinical Investigation